BioSpace News Archive

Eiger BioPharmaceuticals, Inc. (Nasdaq:EIGR) today announced that it will host a conference call on Thursday, November 3, 2022 at 4:30 PM ET to discuss its third quarter 2022 financial results and provide a business update.

Oragenics, Inc., a biotech company dedicated to fighting infectious diseases including COVID-19, announces its participation in the 2022 BioFlorida Annual Conference, being held November 2-4 in Miami.

Vyant Bio, Inc. (“Vyant Bio” or “Company”) (Nasdaq: VYNT) is an innovative biotechnology company reinventing drug discovery for complex neurodevelopmental and neurodegenerative disorders.

Stevanato Group S.p.A. announced that it will issue financial results for the third quarter of 2022 on Tuesday, November 8, 2022, at 6:30 a.m. Conference call and webcast: The Company will host a conference call and webcast at 8:30 a.m. on Tuesday, November 8, 2022 to discuss financial results for the third quarter.

NyxoahSA announced that Raymond Cohen resigned as member of the board of directors of the Company effective October 18, 2022.

Ligand Pharmaceuticals Incorporated announced the business combination of Avista Public Acquisition Corp. II and OmniAb, Inc., was approved by APAC shareholders in a vote held this morning, with 96% of the shares represented in person, virtually or by proxy voting in favor of the combination.

Taysha Gene Therapies, Inc. announced that it will host a conference call and webcast with slides to discuss Astellas Pharma’s strategic investment to support the development of two of Taysha’s AAV-based gene therapy programs, TSHA-102 for Rett syndrome and TSHA-120 for giant axonal neuropathy, on Tuesday, October 25, 2022, at 8:00 AM Eastern Time.

Medtronic plc, a global leader in healthcare technology, announced it will participate in the Chief Executives for Corporate Purpose’s 10th CEO Investor Forum held at AdvaMed’s 2022 MedTech Conference on Tuesday, October 25, 2022, in Boston, MA.

Urethral stricture, blocking the passage of urine from the bladder in men, could be solved by BEES-HAUS cell therapy, a novel autologous buccal mucosal cell-based approach as reported by Dr. Akio Horiguchi an eminent urologist.

The Bill & Melinda Gates Foundation announced a series of initiatives and a call for proposals to advance locally-led innovation that supports work by scientists and researchers in developing economies.